OraSure Technologies to Participate At the UBS Global Life Sciences Conference

• Press Release
• Source: OraSure Technologies, Inc.
• On 8:00 am EDT, Thursday September 17, 2009

BETHLEHEM, Pa., Sept. 17, 2009 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR - News) today announced that Douglas A. Michels, President and Chief Executive Officer, will speak to the investment community at the UBS Global Life Sciences Conference in New York City at approximately 8:30am Eastern Time (5:30am Pacific Time), on Tuesday, September 22, 2009. The conference will be simultaneously webcast over the Internet.

Related Quotes

Symbol	Price	Change
OSUR	3.94	-0.16

{"s" : "osur","k" : "c10,l10,p20,t10","o" : "","j" : ""}

Interested investors can access the live audio webcast of the discussion by going to OraSure Technologies' web site, www.orasure.com, and clicking on the Investor Information link. A replay of the audio webcast will be available until September 29, 2009 on OraSure Technologies' web site.

About OraSure Technologies

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. For more information on the Company, please go to www.orasure.com.

The OraSure Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6440

OraSure Technologies, Inc.
Ronald H. Spair, Chief Financial Officer
610-882-1820
Investorinfo@orasure.com
www.orasure.com